Biogened S.A.

zł 19.00As of Sun 8 Nov 2026, 12:00 UTC
WSE:BGDHealthcare
Country Poland
PE (Fwd) •••
TSR 10Y CAGR 5.43%
Div yield 2.63%
ROE 11.20%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.03
PE TTM 9.105
TSR TTM (7.04%)
Mkt cap zł 46.67M
ROIC 9.77%
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 22
16.29%
215.80%
Hold 8|5|12|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.46
0.51
0.54
0.53
11.04%
27.27%
24.05%
22.32%
Revenuezł M
5.367
5.523
5.778
6.071
2.15%
4.37%
8.08%
9.79%
Peers (US$11.79M)
Cap (US$)
PE
221.7M
7.989x
12.08M
25.54x
Capital
TTM
5Y
10Y
Leveragex
1.039
0.190
0.184
EBIT/Intx
3.473
0.141
0.149
Own earn%
73.59
(38.17)
(38.14)
Sh yield%
40.94
13.84
19.55
Owners
Insiders/Inst%
3.44
81.20
Short interest%
5.55
SBC / revenue%
5.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
3